DermaSensor Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series B1
- Latest Deal Amount
-
$10M
- Investors
-
14
DermaSensor General Information
Description
Developer of a skin cancer evaluation technology designed to provide spectroscopy and machine learning technologies to detect skin cancer early. The company's technology utilizes elastic scattering spectroscopy technology and machine learning algorithms to track and differentiate cancerous skin and send alerts and notifications when such cells are detected, enabling patients to efficiently check for skin cancer at homes and clinics without having to wait for time-consuming diagnostic reports.
Contact Information
Website
www.dermasensor.com.auCorporate Office
- P.O. Box 310703
- Miami, FL 33231
- United States
Corporate Office
- P.O. Box 310703
- Miami, FL 33231
- United States
DermaSensor Timeline
DermaSensor Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series B1) | 15-Jun-2022 | $10M | Completed | Generating Revenue | ||
7. Accelerator/Incubator | 01-Jun-2022 | Completed | Generating Revenue | |||
6. Later Stage VC (Series B) | 20-Dec-2021 | Completed | Generating Revenue | |||
5. Later Stage VC (Series A2) | 05-Jun-2020 | Completed | Generating Revenue | |||
4. Debt - PPP | 03-May-2020 | Completed | Generating Revenue | |||
3. Later Stage VC (Series A1) | 17-Mar-2020 | Completed | Generating Revenue | |||
2. Later Stage VC | 18-Dec-2018 | $5.81M | $5.81M | Completed | Generating Revenue | |
1. Accelerator/Incubator | 03-Feb-2018 | Completed | Generating Revenue |
DermaSensor Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A2 | ||||||||
Series A1 | 129,000,000 | $0.000100 | $0.12 | $0.12 | 1x | $0.12 | 46.35% |
DermaSensor Patents
DermaSensor Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220378295-A1 | Dynamic calibration of light intensity in a system for non-invasive detection of skin cancer using elastic scattering spectroscopy | Active | 21-May-2021 | ||
EP-4340710-A1 | Dynamic calibration of light intensity in a system for non-invasive detection of skin cancer using elastic scattering spectroscopy | Pending | 21-May-2021 | ||
US-12053263-B2 | Dynamic calibration of light intensity in a system for non-invasive detection of skin cancer using elastic scattering spectroscopy | Active | 21-May-2021 | ||
US-20240341602-A1 | Dynamic calibration of light intensity in a system for non-invasive detection of skin cancer using elastic scattering spectroscopy | Pending | 21-May-2021 | ||
US-20130253335-A1 | Optical process and apparatus for non-invasive detection of melanoma | Active | 08-Mar-2012 | A61B5/0075 |
DermaSensor Signals
DermaSensor Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alberto Beeck | Angel (individual) | Minority | ||
Ceros Capital Markets | Venture Capital | Minority | ||
Ernest Bachrach | Angel (individual) | Minority | ||
Kern Venture Group | Venture Capital | Minority | ||
MedTech Innovator | Accelerator/Incubator |
DermaSensor FAQs
-
When was DermaSensor founded?
DermaSensor was founded in 2009.
-
Where is DermaSensor headquartered?
DermaSensor is headquartered in Miami, FL.
-
What is the size of DermaSensor?
DermaSensor has 27 total employees.
-
What industry is DermaSensor in?
DermaSensor’s primary industry is Diagnostic Equipment.
-
Is DermaSensor a private or public company?
DermaSensor is a Private company.
-
What is DermaSensor’s current revenue?
The current revenue for DermaSensor is
. -
How much funding has DermaSensor raised over time?
DermaSensor has raised $41.7M.
-
Who are DermaSensor’s investors?
Alberto Beeck, Ceros Capital Markets, Ernest Bachrach, Kern Venture Group, and MedTech Innovator are 5 of 14 investors who have invested in DermaSensor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »